Two dogs with iatrogenic discospondylitis caused by meticillin-resistant Staphylococcus aureus

Two dogs developed discospondylitis caused by meticillin-resistant Staphylococcus aureus following thoracolumbar hemilaminectomy. Diagnoses were established by magnetic resonance imaging and radiography, respectively, in conjunction with culturing of microbial swabs. Treatment with β-lactam antibiotics was first initiated. As soon as culturing results, confirming meticillin-resistant Staphylococcus aureus infection, and antibiograms became available, antimicrobial therapy was changed to gentamicin and trimethoprim/sulphadiazine. One dog, however, deteriorated further and was euthanased. The other dog improved on appropriate therapy. The first attempt to discontinue drug therapy four months after surgery led to a relapse. Antimicrobial therapy with chloramphenicol was then initiated and maintained for an additional four months. This dog is free of any relapses for 2·5 years. The veterinary surgeon should be aware of the possible involvement of meticillin-resistant Staphylococcus aureus in postsurgical discospondylitis when choosing an antibiotic for initial antimicrobial therapy while culturing results are still pending.     

Surgical treatment of lumbosacral instability caused by discospondylitis in four dogs

OBJECTIVE: To describe a surgical technique involving distraction and stabilization of the lumbo-sacral vertebral segment using an external skeletal fixator in dogs with lumbosacral instability caused by discospondylitis. STUDY DESIGN: Retrospective clinical study. ANIMALS: Four client-owned dogs. METHODS: Medical records of all dogs diagnosed with discospondylitis from 1994 to 1997 were identified and reviewed. Four dogs with lumbosacral discospondylitis requiring surgical treatment were then specifically studied. Surgical technique, clinical signs, preoperative diagnostic investigation, radiographic findings, and the results of short-term and long-term reevaluations were recorded. RESULTS: Twelve dogs with discospondylitis were identified, 4 of which had lumbosacral discospondylitis. These 4 dogs underwent surgical distraction and stabilization because they failed to respond to medical treatment. Three dogs received a cancellous bone graft between L7 and S1 and had rapid interbody fusion of this vertebral segment. The dog that did not receive a graft did not have interbody fusion at the time of fixator removal. This did not affect the final clinical outcome. Lumbosacral pain and neurological deficits present before surgery rapidly subsided after the procedure. All dogs received concurrent antibiotic treatment for a minimum of 4 weeks. All dogs were clinically normal at the time of fixator removal and all continued to do well during the follow-up period (8-48 months; mean, 27.5 months). CONCLUSION AND CLINICAL RELEVANCE: Lumbosacral discospondylitis may not respond well to conservative treatment because of the mobility of the affected space. Surgical treatment involving distraction and stabilization to obtain intervertebral fusion is very effective in treating lumbosacral instability caused by discospondylitis.     

Treatment of discospondylitis in the dog.

A combination of spinal cord decompression, spinal column immobilization, and systemic antibiotic therapy was used to treat discospondylitis in 30 dogs. Recovery was complete in 7 of 9 dogs with cervical involvement and in all 21 dogs with thoracolumbar involvement.     

Partial percutaneous discectomy for treatment of thoracolumbar disc protrusion: retrospective study of 331 dogs

OBJECTIVES: To determine retrospectively the prognosis and outcome for dogs diagnosed with thoracolumbar intervertebral disc disease treated with partial percutaneous discectomy (PPD). METHODS: Three hundred and thirty-one dogs presenting with symptoms of thoracolumbar intervertebral disc disease from 1998 to 2003 were treated with PPD. Diagnosis and location of intervertebral disc disease was confirmed by clinical examination, radiography, myelography and magnetic resonance imaging. PPD was performed via fluoroscopy-guided removal of a 5 mm bore cylinder out of the central intervertebral space. RESULTS: Clinical success after surgery was achieved in 159 (88.8 per cent) grade II to IV patients and 58 (38.2 per cent) grade V patients. The mean (sd) time from percutaneous discectomy to first improvement was 8.3 (13.2) days. CLINICAL SIGNIFICANCE: The PPD approach to the thoracolumbar spine involves minor trauma (yielding rapid recovery) and less pain, and produces results comparable with open fenestration. Consequently, this simple minimal invasive technique can be recommended as an alternative to the technique of fenestration and can be easily performed in addition to open surgical decompression techniques or prophylactically. However, it is not a replacement for surgical treatment in dogs with thoracolumbar disc disease that require removal of disc fragments causing spinal cord or nerve root compression.     

MRI findings in a dog with discospondylitis caused by Bordetella species

A case of discospondylitis in a dog secondary to Bordetella species, diagnosed early with the assistance of magnetic resonance imaging (MRI), is reported. The history and clinical signs were suggestive of possible discospondylitis. MRI identified changes and allowed a presumptive diagnosis of discospondylitis, which was subsequently confirmed by bacterial culture of biopsy material. Discospondylitis associated with Bordetella species infection has not, to the authors' knowledge, been previously reported in the dog.     

Treatment of tibial fractures with plates using minimally invasive percutaneous osteosynthesis in dogs and cats

OBJECTIVES: The aim of the here described case series was to develop and evaluate the minimally invasive percutaneous osteosynthesis for the plate fixation of tibial fractures in dogs and cats. METHODS: Six dogs and four cats with shaft fractures of the tibia were treated using minimally invasive percutaneous osteosynthesis. Follow-up radiographs four to six weeks after fracture fixation were evaluated for fracture healing. For the long-term follow-up (minimum 2.4 years), owners were contacted by phone to complete a questionnaire. RESULTS: All fractures healed without the need for a second procedure. Follow-up radiographs obtained after four to six weeks in seven cases showed advanced bony healing with callus formation and filling of the fracture gaps with calcified tissue in all seven. All the patients had a good to excellent long-term result with full limb function. The time needed for regaining full limb use was two to three months. CLINICAL SIGNIFICANCE: Minimally invasive percutaneous osteosynthesis seems to be a useful technique for the treatment of tibial shaft fractures in dogs and cats.     

Surgical treatment of lumbosacral discospondylitis by a distraction-fusion technique

Lumbosacral discospondylitis was diagnosed in three adult dogs by radiography and the isolation of Staphylococcus aureus from the affected intervertebral space. The predominant clinical findings of severe spinal pain and marked hindlimb lameness suggested entrapment of the seventh lumbar spinal nerve roots. In addition, the presence of hindlimb ataxia, proprioceptive deficits, perineal analgesia and paresis of the tail were consistent with compression of the cauda equina. Despite medical therapy with analgesics, antibiotics and strict confinement the clinical and radiographic signs progressed. A lumbosacral distraction-fusion procedure was employed to decompress the spinal nerve roots and cauda equina and to stabilise the affected vertebrae. In all cases there was an immediate marked reduction in spinal pain and a long term resolution of clinical signs. In two cases the affected vertebrae progressively fused within four months. The third case required removal of the implants due to pin migration and breakage.     

Treatment of periodontitis in dogs with tinidazole

The efficacy of tinidazole administered in addition to a single course of scaling was evaluated in the treatment of periodontitis in 14 small dogs. Periodontal parameters, such as pocket depth, gingival bleeding after probing, furcation involvements and tooth mobility, were examined at baseline, 14 days, and three and six months. After thorough scaling and root planing, tinidazole (15 to 25 mg/ kg) or placebo was given orally twice daily for seven days. Tinidazole plus scaling resulted in a statistically significant decrease from the baseline values in the mean pocket depth, percentage of deep (greater than 3 mm) pockets and frequency of gingival bleeding for six months. In the placebo plus scaling group, mean pocket depth, percentage of deep pockets, frequency of gingival bleeding and number of furcation involvements were significantly lower at 14 days than at baseline. The decrease in bleeding tendency was significantly greater in the tinidazole than in the placebo group at the first two follow-up visits. Similarly, pocket depth and the percentage of deep pockets at the last two visits had decreased significantly more in the tinidazole group than in the placebo group. The use of tinidazole in addition to scaling seems to result in longer lasting improvement of the periodontal condition in dogs with periodontitis than scaling alone.     

碘伏对观赏犬子宫炎的治疗

子宫内膜炎是观赏犬生殖系统的常见病 ,也是观赏犬繁殖障碍的重要原因。用碘伏治疗 ,具有操作简便、疗效确实、无其他并发症等许多优点。1　临床诊断　从病犬阴门排出灰黄色或红褐色或灰白色脓性分泌物 ,具有臭味。阴门稍肿大、松弛 ,病犬爱用舌舔。体温有时 40℃以上 ,精神不振 ,喜卧 ,频频排尿 ,但每次排尿少。食欲减退或拒食 ,常常转为慢性经过。2　阴道检查　阴道内有不洁分泌物、异臭。子宫颈口充血、肿胀、松弛、开张 ,并可见有分泌物从中流入阴道内。3　腹壁触诊　可感子宫缺乏弹性 ,子宫壁增厚 ,当子宫腔有炎性分泌物蓄积时 ,则有波…     

Treatment of wobbler syndrome in dogs with electroacupuncture

Based on favorable experiences with acupuncture for the treatment of hind limbs paralysis, lumbo-sacral alterations, and other spinal cord problems; a clinical trial, involving 40 dogs affected with wobbler syndrome was carried out. Patients were graded in three categories according to the severity of each case and then randomly divided in two groups. Both groups contained all three grades. Group 1 (20 dogs) was treated using orthodox medical and surgical interventions, while Group 2 (20 dogs) were treated mainly with electroacupuncture, and in few cases with surgical intervention as well. The study was carried out in a three-year period. Acupuncture treatments were given every other day delivering 150 to 300 mVolts at 125 Hz, equivalents to approximately 20 microAmps, in ten acupuncture points per treatment. Deep needle insertion was used. Overall per cent success in Group I was only 20%, while in group II the corresponding value was 85%. The number of acupuncture treatments required to achieve full recovery in Group II was dependent upon the severity of the case, as follows: Grade I: 18.5 +/- 2.5; Grade II: 25 +/- 5.4; and Grade III: 34 +/- 6.7 (r = 0.962). No adverse effects were observed with acupuncture. The use of this technique is proposed for large-scale clinical trials.     

Treatment with gabapentin of 11 dogs with refractory idiopathic epilepsy

Eleven dogs diagnosed with refractory idiopathic epilepsy were treated orally with gabapentin for a minimum of three months at an initial dose of 10 mg/kg every eight hours. They were all experiencing episodes of generalised tonic-clonic seizures and had been treated chronically with a combination of phenobarbital and potassium bromide at doses sufficient to reach acceptable therapeutic serum levels without causing significant side effects. In each dog, the number of seizures per week, the average duration of the seizures and the number of days on which seizures occurred were compared for the three months before and after they were treated with gabapentin. A minimum 50 per cent reduction in the number of seizures per week was interpreted as a positive response to gabapentin, and six of the dogs showed a positive response. After the addition of gabapentin, both the number of seizures per week (P= 0.005) and the number of days with any seizures in a one-week period (P=0.03) were significantly reduced. Mild side effects of ataxia and sedation were observed in five of the dogs, but they were not severe enough to warrant the treatment being discontinued during the trial.     

Treatment with DAV for advanced-stage hemangiosarcoma in dogs

Hemangiosarcoma (HSA) is an aggressive disease that is fairly common in the dog. The authors evaluated a doxorubicin, dacarbazine, and vincristine (DAV) combination protocol in dogs with nonresectable stage II and stage III HSA. Twenty-four dogs were enrolled in this prospective, phase 2 study. Doxorubicin and dacarbazine were administered on day 1 while vincristine was administered on days 8 and 15. The protocol was repeated every 21 days for a maximum of six cycles or until disease progression. Toxicity and efficacy were assessed by clinical and laboratory evaluation and by questionnaires completed by the owners. Of the 24 included dogs, 19 were evaluable for response. The response rate (including five complete responses and four partial responses) was 47.4%. Median time to tumor progression was 101 days and median overall survival was 125 days. Significant toxicities were noted, including 41 high-grade hematologic and 12 high-grade gastrointestinal toxic events. Five dogs discontinued treatment due to chemotherapy-related toxicities, but no treatment-related deaths occurred. Multivariate analysis identified patient age (relative risk [RR], 2.3, P=0.049) to be negatively associated with time to progression whereas dacarbazine dose reductions (RR, 0.06, P=0.031) were positively associated with time to progression. Dacarbazine dose reduction was the sole factor positively associated with overall survival (RR, 0.28, P=0.015). In conclusion, the DAV combination appears to offer clinical responses and may prolong survival in dogs with advanced-stage HSA.     

Treatment of spontaneous malignant tumours in dogs with PTMC

The chemical analysis of the caffeine salt of a phosphomolybdic-tungstic acid compound (PTMC) is described. Twenty-seven dogs with advanced malignant tumours have been treated with PTMC by intramuscular or intravenous injection. Five dogs - one case of metastatic osteosarcoma, two cases of metastatic mammary carcinoma, one case of metastatic squamous cell carcinoma and one case of primary fibrosarcoma showed objective tumour regression for periods varying from four weeks to 20 months. Only two of the 27 dogs treated showed toxic effects.